Question of the Day

Question of the Day – Wednesday July 17, 2019

Question – Onset of the so-called Antabuse reaction may begin after alcohol is consumed by a person who has ingested inky cap mushrooms (Coprinopsis atramentaria). How long following alcohol consumption after eating inky caps can this Antabuse reaction be triggered?

 

View full post for answer.

Question of the Day – Wednesday July 10, 2019

Question – PD-1/PD-L1 inhibitors have recently been approved for the treatment of a number of malignancies. The use of PD-1 axis inhibition is drastically changing the use of immunotherapy in cancer. What are the novel immune related adverse effects associated with the use of these agents?

View full post for answer.

Question of the Day – Tuesday July 9, 2019

Question – The article cited below reports the drug “Dexmedetomidate induces sedation while preserving a degree of arousability among patients in the intensive care unit (ICU), and its use has resulted in a shorter time to extubation, an increased number of days free from coma or delirium, a reduced incidence of agitated delirium, prevention of delirium, and lower mortality than other agents administered in certain populations.” What adverse effects are reported in association with the administration of dexmedetomidate?

View full post for answer.